Annovis Bio, Inc.ANVSNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank13
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-852.66M
↑ 66% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-2.54B
Historical baseline
PeriodValueYoY Change
TTM$-852.66M+96.1%
2024$-21.89B-54681.3%
2023$-39.97M-130.9%
2022$-17.31M-89.6%
2021$-9.13M-130.0%
2020$-3.97M-733.3%
2019$-476542.00+14.7%
2018$-558609.00-3.9%
2017$-537481.00-